COMP <GO>
IREN vs MS // 10Y YIELD & FRED MACRO BETA
IREN Limited (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: IREN 7
— MS 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: IREN
LAST: $23.95 (-8.76%) • MKT CAP: $10.62B
macro-sensitivity
1.08
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
macro-sensitivity
1.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 41.00% | +27.30 | IREN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 3.00% | -1.80 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 31.0x | -12.70 | IREN | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | -7.25% | +4.17 | IREN | /fcf-yield <GO> |
| Operating Margin | 3.50% | 24.60% | -21.10 | MS | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 20.20% | -2.80 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 5.50% | +162.20 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.21% | -2.21 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 0.46 | +1.42 | IREN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.00% | +0.20 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 43.3 | -13.10 | MS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 1.04 | +0.04 | IREN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 16.5x | +86.10 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $298.41B | -$287.79B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | MS REV | IREN GROSS % | MS GROSS % | IREN FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $0 | 68.3% | — | -$327.6M | -$17.89B |
| FY 2024 | $187.2M | $0 | 53.5% | — | -$89.6M | $1.36B |
| FY 2023 | $75.5M | $0 | 44.0% | — | $2.3M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
MS // BETA 1.04